High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

Allopurinol Offers No Heart Benefit in Kidney Donors

The use of allopurinol leads to significantly lower uric acid levels but shows no effect on heart mass, blood pressure, or insulin sensitivity in healthy living kidney donors, a phase 2b trial finds.

Retatrutide Trims Weight and A1c in Diabetes

Retatrutide helped patients lose up to 30% of body weight in new trials, among the largest effects yet from a weight-loss drug – but a new safety signal raises questions.

Quarter of Gestational Diabetes Moms Get Early Hypertension

More than 1 in 4 women with recent gestational diabetes developed hypertension at 5 months postpartum, driven primarily by baseline maternal characteristics rather than pregnancy complications.

Cardiometabolic Index Can Predict Mortality Risk in T2D

A higher cardiometabolic index is linked to an increased risk for all-cause and cardiovascular mortality in patients with T2D, serving as an effective prognostic tool.

Three Midlife Risk Factors Linked to Earlier Dementia Onset

Smoking, diabetes, and hypertension in midlife are associated with nearly 13 fewer dementia-free years, underscoring the importance of vascular risk management.

Even Low Physical Activity May Lower Stroke Risk in AF

Even low levels of physical activity were linked to lower stroke and mortality risks in atrial fibrillation, with greater benefits generally seen at higher activity levels.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

The use of allopurinol leads to significantly lower uric acid levels but shows no effect on heart mass, blood pressure, or insulin sensitivity in healthy living kidney donors, a phase 2b trial finds.

Retatrutide helped patients lose up to 30% of body weight in new trials, among the largest effects yet from a weight-loss drug – but a new safety signal raises questions.

More than 1 in 4 women with recent gestational diabetes developed hypertension at 5 months postpartum, driven primarily by baseline maternal characteristics rather than pregnancy complications.

A higher cardiometabolic index is linked to an increased risk for all-cause and cardiovascular mortality in patients with T2D, serving as an effective prognostic tool.

Smoking, diabetes, and hypertension in midlife are associated with nearly 13 fewer dementia-free years, underscoring the importance of vascular risk management.

Even low levels of physical activity were linked to lower stroke and mortality risks in atrial fibrillation, with greater benefits generally seen at higher activity levels.

News All Time

GLP-1s Work Better After Bariatric Surgery

Patients who start GLP-1s after bariatric surgery, not before, live longer and have fewer complications.

Healthy Grocery Delivery Curbs Blood Sugar Levels in T2D

A new study looks at the effect of home delivery of healthy groceries on A1c levels and food and nutrition security in vulnerable patients with type 2 diabetes.

How Braunwald Changed Medicine and Navigated Research Fraud

Genius or hard work? How did Eugene Braunwald become the father of modern cardiology.

Pregnancy Weight Gain, Hypertension Tied to JIA Risk in Kids

Higher weight gain and hypertensive disorders during pregnancy are associated with an increased risk for juvenile idiopathic arthritis in children, and prepregnancy BMI shows no association.

Cardiac Output Tied to Brain Volume in APOE-ε4 Carriers

Reduced cardiac output is associated with a smaller brain volume in older adults carrying the APOE-ε4 allele, but not in non-carriers, a study shows.

Braunwald’s Uncertain Beginnings and Concerns for the US

Eugene Braunwald’s life was full of close calls. Medscape spoke with cardiologist Thomas Lee about how he came to write the eminent physician’s biography and the last time he spoke with Braunwald.

Capillary Changes Tied to Higher Mortality in Raynaud's

Patients with early Raynaud's phenomenon who show both abnormal nailfold capillaries and positive antinuclear antibodies face a mortality pattern that diverges from those with neither marker.

Forward Head Posture Linked to Altered Spine Alignment

A radiographic analysis reveals that forward head posture involves shifts in the upper cervical and cervicothoracic regions with increased forward spinal balance.

Kidney Function Tied to Small Vessel Disease Marker

Stroke survivors with glomerular hyperfiltration show more enlarged perivascular spaces, while those with severely reduced kidney function have greater overall small vessel disease burden.

UK Becomes First in Europe to Approve New GLP-1 Pill

The MHRA approves orforglipron, making the UK the first country in Europe to approve the weight-loss and diabetes drug.

Plasma p-Tau217 Drop Tied to Better Outcomes on Lecanemab

Patients with Alzheimer's disease show distinct patterns of plasma p-tau217 reduction after starting lecanemab, and those with greater biomarker drops show more favorable cognitive trajectories.

Premature Menopause Linked to Higher Risk for Hypertension

Premature menopause before the age of 40 years is linked to a higher risk for hypertension than normal menopause after the age of 45 years.

Specific Food Ingredients Linked to Risk for Hypertension

Specific food ingredients used in ultraprocessing are linked to a higher risk of developing incident arterial hypertension, a large UK Biobank analysis finds.

Depression Mediates Link Between CAA and Cognitive Decline

Depressive symptoms are more likely in patients with cerebral amyloid angiopathy than in control individuals and partly explain the cognitive deficits in this population.

Levothyroxine Aids Heart Health in Kids With Hypothyroidism

Levothyroxine therapy may improve subtle left ventricular diastolic dysfunction in children with idiopathic subclinical hypothyroidism.

Smoky Air on Hot Days Linked to More Danger for the Heart

A multi-country study shows the impact of wildfire smoke exposure during a heatwave, prompting calls for cardiologists to protect their most vulnerable patients.

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Older Adults With Advanced Cancer Prioritize Quality of Life

FDA approves rivanetin as the first-line treatment for lung cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Comprehensive Updates in Hematology and Quality Improvement 

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Rehabilitation of Physical Endurance Following Prolonged Cytopenic States 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

1.

Emerging Advances in Hematology and Quality Improvement

2.

Practical Breakthroughs in Oncology Across Clinical Settings

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Signs and Symptoms of Leukemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot